Holen Sie sich die Stockscreener-App
9.54
0.00%
0.00
Handel nachbörslich:
9.52
-0.02
-0.21%
Kura Oncology Inc Aktie (KURA) Neueste Nachrichten
Research Analysts Set Expectations for Kura Oncology FY2030 Earnings - MarketBeat
Kura Oncology (NASDAQ:KURA) Stock Price Down 6.1%Here's Why - MarketBeat
Kura Oncology reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Kura Oncology (KURA) Grants Stock Options to New Employees - GuruFocus
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Discipline and Rules-Based Execution in KURA Response - Stock Traders Daily
What analysts say about Kura Oncology Inc stockGeopolitical Risk Analysis & Affordable Trading Portfolio - earlytimes.in
Is Kura Oncology Inc a good long term investmentPrice-to-Book Ratio Updates & Maximize Gains Professionally - earlytimes.in
Kura Oncology Stock: Biotech Battleground With High Hopes And Higher Volatility - AD HOC NEWS
Jim Cramer calls Kura speculative but says "It's one of the stronger ones I've seen in a very long time" - MSN
Kura Oncology rises following Jim Cramer comments - MSN
(KURA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Jim Cramer Calls Kura Speculative But Says "It's One of the Stronger Ones I've Seen in a Very Long Time" - Finviz
Kura Oncology shows market leadership with jump to 93 RS rating - MSN
Kura Oncology (STU:KUR) EV-to-FCF : 3.00 (As of Dec. 23, 2025) - GuruFocus
Kura Oncology completes first U.S. commercial sale of KOMZIFTI - MSN
7 Stocks That Were on Jim Cramer’s Radar - Insider Monkey
Kura Oncology (KURA) Shares Surge After FDA Approval and Cramer Endorsement - GuruFocus
Kura Oncology (NASDAQ:KURA) Shares Gap UpHere's Why - MarketBeat
Kura Oncology (STU:KUR) EV-to-OCF : 2.87 (As of Dec. 22, 2025) - GuruFocus
Jim Cramer Discusses Kura Oncology as a Speculative Bet - Finviz
Kura Oncology (HAM:KUR) EV-to-OCF : 2.87 (As of Dec. 21, 2025) - GuruFocus
Jim Cramer discusses Kura Oncology as a speculative bet - MSN
Kura Oncology, Inc. $KURA Stock Position Lifted by Assenagon Asset Management S.A. - MarketBeat
Jim Cramer’s Latest Insights on These 13 Stocks - Insider Monkey
How the Narrative Surrounding Kura Oncology Is Changing After Komzifti Approval - Yahoo Finance
KURA (Kura Oncology) EV-to-OCF : 3.72 (As of Dec. 20, 2025) - GuruFocus
Francis Burrows Sells 23,726 Shares of Kura Oncology (NASDAQ:KURA) Stock - MarketBeat
Kura Oncology Chief Scientific Officer Sells Shares - TradingView — Track All Markets
Is Kura Oncology Inc. stock affected by interest rate hikesMarket Growth Summary & Weekly High Return Stock Forecasts - DonanımHaber
Why analysts upgrade Kura Oncology Inc. stockWeekly Gains Summary & Daily Volume Surge Trade Alerts - DonanımHaber
Will Kura Oncology Inc. stock see insider buyingJuly 2025 PreEarnings & Low Risk High Win Rate Picks - DonanımHaber
Officer Burrows Files To Sell 23,726 Of Kura Oncology Inc [KURA] - TradingView — Track All Markets
Kura Oncology (NASDAQ:KURA) Shares Down 3.5%Here's Why - MarketBeat
Kura Oncology (KURA) Gains Momentum as Barclays Sees Significant Potential in Ziftomenib Approval - Finviz
Kura Oncology (KURA) gains momentum as Barclays sees significant potential in Ziftomenib approval - MSN
Kura Oncology, Inc. (KURA) Discusses Ziftomenib Combination Data in Newly Diagnosed and Relapsed/Refractory NPM1-m and KMT2A-r AMLSlideshow (NASDAQ:KURA) 2025-12-15 - Seeking Alpha
20 Stocks That Will Double in 2026 - Insider Monkey
Kura Oncology, Inc. (NASDAQ:KURA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
EcoR1 Capital LLC Boosts Stock Position in Kura Oncology, Inc. $KURA - MarketBeat
(KURA) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Kura Oncology, Inc. $KURA Shares Sold by Armistice Capital LLC - MarketBeat
Kura Oncology, Kyowa Kirin reveal Komsifti combo data for AML - MSN
Insider Sell: Faheem Hasnain Sells 10,000 Shares of Kura Oncology Inc (KURA) - GuruFocus
Kura Oncology Director Sells 10,000 Shares - TradingView — Track All Markets
Dir Hasnain Sells 10,000 ($109.8K) Of Kura Oncology Inc [KURA] - TradingView — Track All Markets
Insiders Find Solace Selling US$1.4m In Stock With Kura Oncology's Price Down 11% - 富途牛牛
Barclays Reaffirms Their Buy Rating on Kura Oncology (KURA) - The Globe and Mail
Dir Hasnain Files To Sell 10,000 Of Kura Oncology Inc [KURA] - TradingView — Track All Markets
Kura Oncology (NASDAQ:KURA) Shares Down 4.6%What's Next? - MarketBeat
Kura Oncology stock maintains Market Outperform rating at Citizens By Investing.com - Investing.com Canada
Kura Oncology, Inc. (KURA) Fundamental Analysis - Meyka
Kura Oncology (KURA) Reports Promising AML Trial Results - GuruFocus
Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI™ (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML - Sahm
Kura Oncology, Kyowa Kirin Report 'Encouraging' Drug Combo Data to Treat Acute Myeloid Leukemia - marketscreener.com
Kura Oncology & Kyowa Kirin announce positive Komzifti combination data for acute myeloid - marketscreener.com
2.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):